Back to User profile » Dr Rongping Guo

Papers published by Dr Rongping Guo:

Original Research

Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis

Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, Wei W, Guo R

Journal of Hepatocellular Carcinoma 2024, 11:665-678

Published Date: 4 April 2024

Original Research

Nomogram Based on Inflammatory Biomarkers to Predict the Recurrence of Hepatocellular Carcinoma—A Multicentre Experience

Zheng Z, Guan R, Zou Y, Jian Z, Lin Y, Guo R, Jin H

Journal of Inflammation Research 2022, 15:5089-5102

Published Date: 5 September 2022

Original Research

Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy

Mei J, Sun XQ, Lin WP, Li SH, Lu LH, Zou JW, Wei W, Guo RP

Journal of Inflammation Research 2021, 14:3879-3890

Published Date: 11 August 2021

Original Research

Prognostic Value of the Preoperative Lymphocyte-C-Reactive Protein Ratio in Hepatocellular Carcinoma Patients Treated with Curative Intent: A Large-Scale Multicentre Study

Zhang YF, Lu LH, Zhong C, Chen MS, Guo RP, Wang L

Journal of Inflammation Research 2021, 14:2483-2495

Published Date: 10 June 2021

Original Research

Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models

Zhang YF, Shi M, Lu LH, Wang L, Guo RP

Journal of Hepatocellular Carcinoma 2021, 8:253-261

Published Date: 19 April 2021

Original Research

Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

Mei J, Li SH, Li QJ, Sun XQ, Lu LH, Lin WP, Zheng L, Chen MS, Shi M, Wei W, Guo RP

Journal of Hepatocellular Carcinoma 2021, 8:167-176

Published Date: 25 March 2021